Clinical Trials

Reliance obtains DCGI approval to conduct Phase I Covid-19 vaccine trial

9th September 2021

Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use

Reliance Life Sciences has obtained approval from the Drugs Controller General of India (DCGI) to carry out a Phase I...

I-Mab Reports Positive Interim Analysis from Phase 2/3 Study of its GM-CSF Antibody Plonmarlimab to Treat Patients with Severe COVID-19

by Content Team

12th August 2021

Sorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD Project

I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced positive interim data from...

Valneva Initiates Further Phase 3 Clinical Trial for its COVID-19 Vaccine Candidate

by Content Team

12th August 2021

Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant...

AzurRx expands trial of drug for Covid-19-linked GI infections to Ukraine

by Content Team

12th August 2021

Charities Pay $6 Million to Settle Medicare Kickback Allegations in Pharma Probe

AzurRx BioPharma has expanded the ongoing Phase II RESERVOIR clinical trial of FW-1022 for the treatment of Covid-19-related gastrointestinal (GI)...

INOVIO Doses First Participant in Phase 2 Trial for its DNA Vaccine Against Middle East Respiratory Syndrome (MERS), a Coronavirus Disease

by Content Team

12th August 2021

DCGI nod to Serum-Oxford covid-19 vaccine for phase 2, 3 clinical trials in India

INOVIO, a biotechnology company bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer,...

Lilly and Incyte’s baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation

by Content Team

5th August 2021

U.S. FDA Approves DARZALEX Split-Dosing Regimen

Eli Lilly and Company and Incyte announced results from an additional cohort of 101 adult patients from the COV-BARRIER trial....

AstraZeneca’s Vaxzevria showed no increased incidence of thrombosis with thrombocytopenia after second dose

by Content Team

2nd August 2021

Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials

Rates of the very rare clotting disorder, thrombosis with thrombocytopenia syndrome (TTS), following a second dose of Vaxzevria are comparable...

New Analysis Supports Medisafe’s Impact on Medication Persistence, Adherence

by Content Team

9th July 2021

Bharat Biotech concludes final analysis for Covaxin efficacy from phase 3 clinical trials

by Content Team

9th July 2021

Bharat Biotech signs agreement with Precisa Medicamentos to supply Covaxin to Brazil

Bharat Biotech, a global leader in vaccine development and innovation, announced safety and efficacy analysis data from Phase III clinical...

RedHill Biopharma’s Opaganib Inhibits COVID-19 Variants in Preclinical Study

by Content Team

9th July 2021

RedHill Biopharma's Opaganib Inhibits COVID-19 Variants in Preclinical Study

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced preliminary results of a new preclinical study showing potent inhibition of COVID-19...

Page 8 of 39 Prev 1 … 7 8 9 … 39 Next

Clinical Trials

Latest News

About Us

Qucik Links

Resources

System

Retrieve your password